Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Metabolism of GLPG1972 in Healthy Men
NCT04136327Phase 1Completed
- Sponsor
- Galapagos NV
- Start
- Sep 2019
- Primary completion
- Oct 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of GLPG1972 in osteoarthritis (OA) (2 arms), sponsored by Galapagos NV. Primary endpoints: Change of total radioactivity excreted in urine and feces combined, Maximum observed plasma concentration (Cmax) of total radioactivity and 4 more. Started Sep 2019; status: completed.
02
Drugs
GLPG1972
03
Conditions
osteoarthritis (OA)
Beyond the preview
Go deeper on NCT04136327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04136327.